By participating in this continuing education program, the attendee should be able to:

  • Describe the framework for IRB review
  • Identify 3 criteria an IRB must consider when determining if a study is approvable
  • Explain considerations that an IRB makes when evaluating risk/benefit ratio, minimization of risks and the composition of the informed consent document.
Robert Baevsky MD, FACEP
Chair Baystate IRB Board
Associate Professor of Medicine
University of Massachusetts Medical School-Baystate
Baystate Medical Center 
Gerald Korona RPh
Vice Chair Baystate IRB Board 1 
Jennifer Pacheco MPH, CIM, CIP
Director Healthcare Research Compliance; Chief Research Compliance Officer 
Peter DePergola II, PhD, MTS
Director Clinical Ethics, Baystate Health
IRB Member Baystate IRB Board 1
Marypat Toye RN , MS, ACRN, CCRP, CPXP
Vice Chair Baystate IRB Board 2

Faculty Disclosure
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

Session date: 
10/17/2019 - 12:00pm to 1:00pm EDT
Baystate Medical Center
759 Chestnut Street
Chestnut 5
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.